TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Diagnostic Performance for the detection of urothelial carcinoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Proportion of mCRPC Patients Achieving PD Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Personal-Social outcome
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: NLS rate
Endpoint domain: Mortality/survival
Primary endpoint: Change in expression of inflammatory cytokines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Functional magnetic resonance imaging of the hypothalamus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Near Visual Acuities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intermediate Acuities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Information in clinical record systems about mental health
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Participants With Ulcer Recurrence
Endpoint domain: Mortality/survival
Primary endpoint: Change in Pain (Worst Pain, Least Pain, Pain Now)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Mean Scores on Quality of Life Measured With the VEINES QOL/Sym Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Maximal Aerobic Capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Work Efficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Microvascular obstruction percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: small intestine function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: skin function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: red blood cell glutathione synthesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: immune capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Levels of avenanthramides and their in vivo metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Rate of Complete Hematologic Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Survival until term without CLD
Endpoint domain: Mortality/survival
Primary endpoint: Rate of Grade 2 or Higher Radiation Pneumonitis
Endpoint domain: Adverse events/effects
Primary endpoint: occurrence of any bleeding episode requiring medical intervention
Endpoint domain: Adverse events/effects
Primary endpoint: Non-distant metastasis survival rate
Endpoint domain: Mortality/survival
Primary endpoint: Number of Participants With Clinically Significant Changes in Clinical Laboratory Test Results Reported as TEAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Clinically Significant Changes in Electrocardiogram (ECG) Reported as TEAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Clinically Significant Changes in Vital Sign Measurements Reported as TEAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Cmax (maximum concentration of midazolam in plasma)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-tz (area under the concentration-time curve of midazolam in plasma)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-infinity (area under the concentration-time curve of midazolam in plasma)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Over the Curve and <60 mg/dl (CGM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mobility measured by Figure-of-eight Walking Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: longitudinal myocardial velocities at rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: systolic functional reserve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: PK parameters of R- and S-warfarin (AUC and Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ocular surface disease index (OSDI) score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Aortic Valve Area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of Major External Beam Radiation Therapy-related Complications
Endpoint domain: Adverse events/effects
Primary endpoint: Objective/histologic responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy against malaria sporozoite challenge
Endpoint domain: Mortality/survival
Primary endpoint: Safety of immunization regimen
Endpoint domain: Adverse events/effects
Primary endpoint: Sex Without a Condom as Assessed by Self-report
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Sexual Abstinence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Prevalence of Sun Protection Practices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of Sunburn
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Internationalized Normalized Ratio (INR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Percentage of Participants With Treatment Failure
Endpoint domain: Adverse events/effects
Primary endpoint: Median Time Used
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Median Number of Contacts
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Extent of bronchial dilatation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Decrease in bronchial dilatation after albuterol incubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in apnoea-hypopnea index (AHI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Intelligence Quotient (IQ) score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Score on the NIH Toolbox Early Childhood Battery
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Score on Adaptive Behavior Assessment System, 3rd edition (ABAS-III)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in HIV status
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of Participants Who Abstained From Smoking
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Device-related MAE
Endpoint domain: Adverse events/effects
Primary endpoint: Total Pain Medication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of severe hypoglycaemia event
Endpoint domain: Adverse events/effects
Primary endpoint: Detection rate of high grade dysplasia and carcinoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Rate of parenteral nutrition completion
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Postoperative complications evaluated by Clavien-Dindo Classification
Endpoint domain: Adverse events/effects
Primary endpoint: emotional-behavioral PISQ-12 score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: physical PISQ-12 score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Median Time to Death From Any Cause
Endpoint domain: Mortality/survival
Primary endpoint: Levels of CEMA in 24-hour urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants with Clinical Remission (DAS28-ESR) in Previous bDMARD Treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants with Clinical Remission (DAS28-ESR) in bDMARD Naïve Participants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Change in SBP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in UPDRS Part II Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quantification of bacteria in the interdental plaque
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Size of Wound Remaining Compared to Initial Wound Size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: monthly income
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: job-tenure
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: working hours
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: time in severe pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: dynamic and static pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower Extremity Function Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Get Up and Go test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knee Outcome Survey - Activities of Daily Living Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Viral Load Suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Activity of Sunitinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Healing of the cartilage injuries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Responder Rate According to the Merz Jawline Assessment Scale (MJAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Reporting One or More Device and/or Injection Related Treatment-emergent Adverse Events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Reporting Device and/or Injection Related Serious TEAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Total VTE Event
Endpoint domain: Adverse events/effects
Primary endpoint: Time to attain therapeutic vancomycin concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: grade 3-5 non-hematological toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Hamilton Depression Rating Scale Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean POC Glucose Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: improvement of symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Overall signal quality of the respiratory polygraph
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Total lesion count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety as assessed by number of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Service Satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Symptomatic Skeletal Events (SSE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in Pressure Time Product of the diaphragm (PTPdi)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in the Release of Skin Flora
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in overall levels of menopausal symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in vasomotor symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Angle between teeth positions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Neurometabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Neural Activation Networks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Baseline-adjusted AUC0-24 for Plasma Total EPA + Total DHA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Baseline-adjusted Cmax for Plasma Total EPA + Total DHA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in acceptability of the Opal app for COVID-19
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in usability of the Opal app for COVID-19
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of Participants With Serious and Non-serious Adverse Events Assessed by the Common Terminology Criteria for Adverse Events (CTCAE v5.0)
Endpoint domain: Adverse events/effects
Primary endpoint: Changes of ROM
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Number of participants with post-operative anastomotic leak
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with post-operative recurrent fistula
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with post-operative anastomotic strictures
Endpoint domain: Adverse events/effects
Primary endpoint: Total number of participants with post-operative complications
Endpoint domain: Adverse events/effects
Primary endpoint: Predictive values of serum CRP, procalcitonin, drain fluid IL-6 and TNF-alpha levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Number of Metaphase II Oocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Mean Number of Mature Oocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Decongestant effect measured by rhinomanometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in the intensity of daily pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the pressure pain threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical pregnancy confirmed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Composite clinical criterion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in vaginal length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in sexual function/satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Occurrence of neovascular glaucoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change of Endothelial function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cognitive Change in clinical symptoms associated with concussion-TBI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Degree of skin fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Hemostatic success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of binding and neutralizing antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Rate of Combined Major Access Site Closure-related Complications
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients cured completely from the disease
Endpoint domain: Mortality/survival
Primary endpoint: Change in Children´s Consumption of Foods
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Children´s Time of Physical Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Score z of Body Mass Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Safety and tolerability of AZD1704
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Positive Treatment-Related Anti-Drug Antibodies (ADA) in Serum
Endpoint domain: Adverse events/effects
Primary endpoint: Change in number of fecal incontinence episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Rate of general postoperative complications
Endpoint domain: Adverse events/effects
Primary endpoint: Change in the aortic aneurysm diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motor Activity Log (MAL) Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle glycogen concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Frequency of definitive diagnoses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Monocular Best corrected distance visual acuity (5 m)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Upper Eye Lid Margin Staining
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Limbal Staining
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Hypersensitivity drug reaction
Endpoint domain: Adverse events/effects
Primary endpoint: Presence of Staphylococcus Aureus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Bone Mineral Density precision
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Worsening heart failure requiring unplanned hospitalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Distance with regard to the anal margin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Initial tumor size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Presence of nodal status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Central Electroencephalography (EEG) Amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Event Related Potential (ERP) Amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Emergence of Suicidal Ideation
Endpoint domain: Adverse events/effects
Primary endpoint: Suicidal Ideation or Suicidal Behavior (C-SSRS)
Endpoint domain: Adverse events/effects
Primary endpoint: Potentially Clinically Significant Vital Sign Values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Potentially Clinically Significant Laboratory Analyte Values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Potentially Clinically Significant Electrocardiograms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Inflammatory Facial Lesion Count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in Bone density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in bone formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: frequency and incidence of all Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Blood concentration of tacrolimus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Propensity to fall
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: chromatin packaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: DNA oxidation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: vacuoles presence in spermatozoa head
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Clinical Mood Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in pain sensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in lactate concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Diagnosis accuracy of ALS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Change From Baseline in Clinical Laboratory Parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Change From Baseline in Electrocardiograms (ECGs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Weight change from baseline to completion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of anti-Ro/SSA IgE positive patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes of right ventricular systolic function (RV-EF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: average IELT change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Plasma HIV-1 RNA Copies Per mL at 168 Hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes